Decheng Capital Global Life Sciences Fund IV, L.P. — insider trades

Stock trades Decheng Capital Global Life Sciences Fund IV, L.P. reported on SEC Form 4 at AARD Aardvark Therapeutics, Inc..

• Feb 14, 2025: bought 1,250,000 shares of AARD Aardvark Therapeutics, Inc. ($20.0M)